Healionics is a company that has developed a novel vascular graft, STARgraft, aimed at providing safer and more reliable means of bloodstream access for dialysis in patients with kidney failure. The company's breakthrough biomaterial scaffold, STAR, has demonstrated superior resistance to occlusion and infection, addressing a severe unmet clinical need for long-term dialysis access.

Healionics

Clinica Ocular is a self-described ophthalmological clinic.

Clinica Ocular

Healionics is a clinical-stage company addressing the critical need for safer, more reliable means of bloodstream access to perform dialysis in patients with kidney failure.  Our STARgraft vascular graft (synthetic blood vessel) is designed to resist the problems of infection and occlusion suffered by current devices.  We also have an exciting product pipeline based on our platform STAR® biomaterial, which has a unique ability to prevent two serious problems that affect all implantable devices:  scarring and infection.  The company is currently conducting human studies of STARgraft and has 33 patents issued or pending.

Tech Coast Angels

Carl Lombardi

Alliance of Angels

ZINO Society

Tacoma Angel Network

Bellingham Angel Organization

Keiretsu Forum

Rockies Venture Club

Mid Atlantic Bio Angels

Keiretsu Capital

Healionics Corporation

I am excited to share that Healionics has been selected to present at the "Best of Keiretsu Forum" Virtual Investment Showcase on December 6th.  Register today to join me: https://bit.ly/49AdOJw
#InvestmentShowcase2023 #BestofKeiretsuForumInvestmentShowcase2023 #KeiretsuForum

In 2019, VisionTech Angels made its first investment in Healionics Corporation. Four years later, 19 VisionTech investors wrote checks totaling $193,000 in a follow-on round to this portfolio company. Congratulations to Mike Connolly and to all those who participated in this round.

VisionTech Partners | VisionTech Angels Ben Pidgeon Angel Capital Association #FollowonRounds

I’ll be presenting a brief update on Healionics this week at the Keiretsu Forum Northwest and Rockies, September 2023 Roadshow.  Register as my guest and get free access to all the events -- https://bit.ly/3r5eghF

Metric
Company Name	Healionics	Clinica Ocular
Symbol
MSH ID	COM:HEALIONICS	CO:COM:CLINICAINSTITUTOOCULAR
Market	PRIVATE	PRIVATE
Sector	Healthcare & Health Services	Healthcare & Health Services
Industry	Healthcare & Health Services	Healthcare
Country	US	CO
Stage
Employee Count	10
Website	healionics.com	clinicainstitutoocular.com.co
LinkedIn	healionics-corporation
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

COM:HEALIONICS

Healionics

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue